NEW YORK (GenomeWeb News) - Vanderbilt University will use GenoLogics’ data-management software for research on colorectal cancer, the company said today.
Researchers at Vanderbilt’s Jim Ayers Institute for Precancer Detection and Diagnostics will use the company’s Proteus system in a program aimed at developing a blood test for early detection of colorectal cancers as well as therapies for targeted treatment of specific tumor types, the company said.
The researchers are using the software to track samples and store data for clinical trials involving thousands of participants, GenoLogics said.
Proteus is enabling the investigators to incorporate clinical data, track non-identifiable patient data, and perform data comparisons involving disease states and tissue proteotypes.
Financial terms of the agreement were not released.